Increases in endoglin (either from loss of CFTR or after plasmid overexpression) amplifies TGF‐β signaling, demonstrating a potentially modifiable pathway to ameliorate TGF‐β pathobiology in CF tissue. This evidence concerns the gene CFTR and cystic fibrosis.